Vaccines

Experts discuss how to tackle biopharma's need to move fast.

A University of Buffalo team has produced a reverse vaccination to help manage the symptoms of various chronic and autoimmune conditions.

Part 2 of our roundtable discussion with CDMOs covers outsourcing preferences, the demand for mRNA, and more.

The efforts of CDMOs have been absolutely crucial in the pandemic response. We ask five CDMO gurus how they reacted to COVID-19.

There’s a lot going on in the world of biopharma but never fear because we’ve got you covered…

With the threat of COVID-19, vaccine developers needed to enter clinical development and scale-up at unprecedented speed.

Though mRNA technologies are helping to expand the industry's horizons, there manufacture does come with challenges.

Applying mRNA technology to the treatment of malaria.

Could mRNA vaccine be the flu interventions of tomorrow?

We sit down with CureVac's Igor Splawski, who discusses the achievements that could define the next chapter of the mRNA success story.